A new approach to safer implants – BellaSeno revolutionizes recontructive medicine
How resorbable 3D-printed implants offer new perspectives for patients – and the role leap:up plays in this development.
Breast reconstruction, soft tissue restoration, bone implants – for a long time, these procedures relied on conventional, permanent materials. But what if there was a solution that fully adapts to the body and eventually dissolves without a trace? This is exactly the revolutionary approach BellaSeno is taking. The company, headquartered in Leipzig with a subsidiary in Brisbane, Australia, develops novel resorbable implants using state-of-the-art 3D printing technologies. Its mission: to provide safe, customized solutions for patients worldwide.
BellaSeno – Innovation from Leipzig with Global Impact
Founded in 2015, BellaSeno is based at the BioCity Campus in Leipzig, a hub for biotechnology and medical technology. The company is ISO 13485 certified and utilizes additive manufacturing technologies to produce implants made from polycaprolactone (PCL) – a material that is gradually broken down by the body while being replaced by natural tissue. This groundbreaking approach avoids the risks of conventional implants and enables more natural reconstruction.
BellaSeno has achieved significant clinical success: In an Australian study on breast augmentation revision, 19 patients successfully completed the one-year follow-up – without major complications. Additionally, a parallel study treated seven patients with pectus excavatum. These positive results pave the way for further studies in Europe and the U.S., aiming for approval of resorbable breast implants.
"The data confirm that our implants are not only safe but also significantly improve patients’ quality of life", says Mohit Chhaya, CEO of BellaSeno. "Our goal is to replace traditional silicone implants with biocompatible alternatives in the long run." Beyond technological innovation, BellaSeno stands out for its international team structure: The company brings together experts from around the world and is considered one of the most diverse biotech startups in Leipzig.
BellaSeno's success is no coincidence. In addition to technological excellence, the biotech cluster leap:up plays a crucial role. The cluster supports the company in international expansion, regulatory challenges, and strategic partnerships.
Key support services provided by leap:up include:
- Regulatory consulting: Assistance with certifications and approval processes to facilitate international market entry.
- Business development: Guidance through growth phases, from scaling production to expanding into new markets.
- Networking and financing:Connecting with investors, cooperation partners, and funding programs.
Thanks to leap:up, BellaSeno can focus on its core expertise: developing safe, innovative, and patient-friendly implant solutions. Leipzig is further solidifying its position as a leading hub for medical technology and biotechnology.
With further clinical studies, a planned expansion into the U.S. and Europe, and continuous support from leap:up, BellaSeno is poised for a promising future. The company impressively demonstrates how 3D printing technology and biomaterial-based implants are revolutionizing medicine – for greater safety, better outcomes, and improved quality of life for patients worldwide.